Effect of Beetroot Powder on diabetes treatment
Phase 3
Recruiting
- Conditions
- Type 2 diabetes mellitus.Type 2 diabetes mellitus
- Registration Number
- IRCT20180409039246N1
- Lead Sponsor
- Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 62
Inclusion Criteria
Non Pregnant and Non Breast Feeding Women
Exclusion Criteria
Women of childbearing age without using a safe Contraceptive method
Smokers and alcohol consumers
Consumers of hormonal medicines
Consumers of antioxidant supplements
Subjects with Heart, Liver, Lung, Chronic Kidney Disease and Thyroid Disorders
Subjects with acute or chronic Inflammatory Diseases
Phosphodiesterase 5 inhibitors, Migraine drugs (such as Sumatriptan), Allopurinol, Tri-rings Antidepressants, Antihistamines, Nitrate-containing drugs, Meperidine, and Sedative Medicines Consumers
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Blood glucose. Timepoint: At baseline of study, 4, 12 and 24 week. Method of measurement: Enzymatic colorimetry.;Hemoglobin glycosylated. Timepoint: At baseline of study, 4, 12 and 24 week. Method of measurement: Enzymatic method.;Triglyceride. Timepoint: At baseline of study, 4, 12 and 24 week. Method of measurement: Enzymatic colorimetry.;High density lipoprotein. Timepoint: At baseline of study, 4, 12 and 24 week. Method of measurement: Enzymatic colorimetry.;Total cholesterol. Timepoint: At baseline of study, 4, 12 and 24 week. Method of measurement: Enzymatic colorimetry.
- Secondary Outcome Measures
Name Time Method